SonoVascular is developing a next-generation, catheter-based solution to more effectively and safely treat blood clots (thrombosis) and has targeted deep vein thrombosis (DVT) and pulmonary embolism (PE) as the first indications.
Location: United States
Total raised: $6M
Investors 1
| Date | Name | Website |
| 10.07.2026 | Band of An... | bandangels... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 04.02.2026 | Series A | $6M | - |
Mentions in press and media 2
| Date | Title | Description |
| 04.02.2026 | SonoVascular Completes First Close of $6M Series A Financing | SonoVascular, Inc., a Chapel Hill, NC-based clinical stage medical device company, completed the first close of its $6M Series A preferred stock financing. The round was led by Harbright Ventures, and Robert Ross, Founding Partner at Harbri... |
| 16.05.2024 | Chapel Hill-based SonoVascular developing new hybrid technology to treat blood clots | In the spirit of building a better mousetrap, medical device startup SonoVascular is developing a new technology to more effectively treat patients who have potentially life-threatening blood clots. The Chapel Hill-headquartered company has... |